In the Journals

End-stage liver disease, HCC common in patients with HCV, bleeding disorders

September 20, 2013
Patients with hepatitis C and inherited bleeding disorders frequently developed end-stage liver disease, with advanced age, HIV coinfection and…
In the Journals

Patients with recurrent HCV benefit from triple therapy after liver transplant

September 16, 2013
Triple therapy was effective in a cohort of liver transplant recipients with recurrent hepatitis C, although adverse events were common in a recent…
In the Journals

Targeted HCV screening effectively identified infected former drug users

September 13, 2013
A hepatitis C screening program targeted toward former injection drug users was effective in identifying infected participants in a recent study…
In the Journals

HCV, waist circumference linked to greater liver stiffness

September 12, 2013
Patients with hepatitis C or HCV/HIV coinfection had significantly more liver stiffness than noninfected patients or those with HIV alone in a recent…
In the Journals

Treated patients with HCV incur lower health care costs

September 11, 2013
Regardless of disease stage or the presence of comorbidities, patients with chronic HCV who received anti-HCV therapy had lower health care costs…
In the Journals

Acute HCV exacerbation yields poor outcomes; does not inhibit SVR

September 9, 2013
While acute exacerbation of chronic hepatitis C worsened fibrosis and necroinflammation in patients, most later responded to interferon-based therapy…
In the Journals

Dietary, activity improvements benefited overweight, obese HCV patients

September 6, 2013
Patients with chronic hepatitis C who undertook low-fat or low-calorie diets and increased their physical activity experienced improvement to…

Research consortium, FDA establish HCV collaboration

September 3, 2013
The Hepatitis C Therapeutic Registry and Research Network has announced a collaboration with the FDA for sharing data on the use and management of…
In the Journals

RVR, baseline characteristics identify patients who will benefit from dual HCV therapy

September 3, 2013
A model incorporating IL28B genotype, fibrosis stage, viral load and rapid virologic response was predictive of benefit from dual therapy among…
In the Journals

Interferon-free regimen shows promise for patients with chronic HCV

August 29, 2013
A 24-week interferon-free regimen of sofosbuvir and ribavirin resulted in a high sustained virologic response rate among hepatitis C virus patients…